127 related articles for article (PubMed ID: 3493148)
21. E-series prostaglandins are potent growth inhibitors for some B lymphomas.
Phipps RP; Lee D; Schad V; Warner GL
Eur J Immunol; 1989 Jun; 19(6):995-1001. PubMed ID: 2546781
[TBL] [Abstract][Full Text] [Related]
22. CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation.
Pezzutto A; Dörken B; Rabinovitch PS; Ledbetter JA; Moldenhauer G; Clark EA
J Immunol; 1987 May; 138(9):2793-9. PubMed ID: 2437199
[TBL] [Abstract][Full Text] [Related]
23. Signaling through murine CD38 is impaired in antigen receptor-unresponsive B cells.
Lund FE; Solvason NW; Cooke MP; Health AW; Grimaldi JC; Parkhouse RM; Goodnow CC; Howard MC
Eur J Immunol; 1995 May; 25(5):1338-45. PubMed ID: 7774637
[TBL] [Abstract][Full Text] [Related]
24. B-Cell suppression in adult mice injected with anti-delta followed by anti-mu mAb.
Chentoufi AA; Nizet Y; Havaux X; Nisol F; Bazin H; Latinne D
Cell Immunol; 2000 Oct; 205(1):40-51. PubMed ID: 11078606
[TBL] [Abstract][Full Text] [Related]
25. Growth regulation of the B lymphoma cell line WEHI-231 by anti-immunoglobulin, lipopolysaccharide, and other bacterial products.
Jakway JP; Usinger WR; Gold MR; Mishell RI; DeFranco AL
J Immunol; 1986 Oct; 137(7):2225-31. PubMed ID: 3489760
[TBL] [Abstract][Full Text] [Related]
26. Co-cross-linking of surface immunoglobulin Fc gamma receptors on B lymphocytes uncouples the antigen receptors from their associated G protein.
Rigley KP; Harnett MM; Klaus GG
Eur J Immunol; 1989 Mar; 19(3):481-5. PubMed ID: 2540010
[TBL] [Abstract][Full Text] [Related]
27. Idiotype vaccination leads to the emergence of a stable surface Ig-negative variant of the mouse lymphoma BCL1, with different growth characteristics.
George AJ; Spellerberg MB; Stevenson FK
J Immunol; 1988 Mar; 140(5):1695-701. PubMed ID: 3162250
[TBL] [Abstract][Full Text] [Related]
28. Lymphoma models for B-cell activation and tolerance. VII. Pathways in anti-Ig-mediated growth inhibition and its reversal.
Warner GL; Scott DW
Cell Immunol; 1988 Aug; 115(1):195-203. PubMed ID: 3261204
[TBL] [Abstract][Full Text] [Related]
29. Anergy in immature B lymphocytes. Differential responses to receptor-mediated stimulation and T helper cells.
Chang TL; Capraro G; Kleinman RE; Abbas AK
J Immunol; 1991 Aug; 147(3):750-6. PubMed ID: 1830597
[TBL] [Abstract][Full Text] [Related]
30. Lymphocyte function-associated antigen (LFA-1) is involved in B cell activation.
Howard DR; Eaves AC; Takei F
J Immunol; 1986 Jun; 136(11):4013-8. PubMed ID: 2422269
[TBL] [Abstract][Full Text] [Related]
31. Activation of B cells in vivo by a Fab/Fc fragment of a monoclonal anti-IgD antibody requires an interaction between the antibody fragment and a cellular IgG Fc receptor.
Goroff DK; Finkelman FD
J Immunol; 1988 May; 140(9):2919-24. PubMed ID: 2966202
[TBL] [Abstract][Full Text] [Related]
32. Role of phosphoinositide-derived second messengers in mediating anti-IgM-induced growth arrest of WEHI-231 B lymphoma cells.
Page DM; DeFranco AL
J Immunol; 1988 Jun; 140(11):3717-26. PubMed ID: 2836499
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the effector mechanism of help for antigen-presenting and bystander resting B cell growth mediated by Ia-restricted Th2 helper T cell lines.
Whalen BJ; Tony HP; Parker DC
J Immunol; 1988 Oct; 141(7):2230-9. PubMed ID: 2971722
[TBL] [Abstract][Full Text] [Related]
34. Idiotype variants emerging after anti-idiotype monoclonal antibody therapy of a murine B cell lymphoma.
Weiner GJ; Kaminski MS
J Immunol; 1989 Jan; 142(1):343-51. PubMed ID: 2783325
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of I-region-associated antigen (Ia) on B cells after cross-linking of surface immunoglobulin.
Mond JJ; Seghal E; Kung J; Finkelman FD
J Immunol; 1981 Sep; 127(3):881-8. PubMed ID: 6790620
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo B lymphocyte-activating properties of monoclonal anti-delta antibodies. I. Determinants of B lymphocyte-activating properties.
Goroff DK; Stall A; Mond JJ; Finkelman FD
J Immunol; 1986 Apr; 136(7):2382-92. PubMed ID: 2419432
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of c-fos expression is a component of the mIg signal transduction mechanism but is not indicative of competence for proliferation.
Monroe JG
J Immunol; 1988 Mar; 140(5):1454-60. PubMed ID: 3126226
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of anti-IgM and growth factor-induced proliferation of guinea pig B cells by one of two distinct Fc gamma receptors on the cells.
Yamashita T; Koyama J
J Immunol; 1988 Nov; 141(9):2889-94. PubMed ID: 2971734
[TBL] [Abstract][Full Text] [Related]
39. B cell tolerance induction by cross-linking of membrane IgM, but not IgD, and synergy by cross-linking of both isotypes.
Gaur A; Yao XR; Scott DW
J Immunol; 1993 Mar; 150(5):1663-9. PubMed ID: 8436810
[TBL] [Abstract][Full Text] [Related]
40. Signaling through CD19, Fc receptors or transforming growth factor-beta: each inhibits the activation of resting human B cells differently.
Barrett TB; Shu GL; Draves KE; Pezzutto A; Clark EA
Eur J Immunol; 1990 May; 20(5):1053-9. PubMed ID: 1694130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
